These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 240790)

  • 1. Studies on lankacidin-group (T-2636) antibiotics. X. Microbial conversion of lankacidin-group antibiotics.
    Nakahama K; Harada S; Igarasi S
    J Antibiot (Tokyo); 1975 May; 28(5):390-4. PubMed ID: 240790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on lankacidin-group (T-2636) ANTIBIOTICS. IX Preparation of C-labeled lankacidin C 14-propionate.
    Hatano K; Harada S; Kishi T
    J Antibiot (Tokyo); 1975 Jan; 28(1):15-20. PubMed ID: 1126865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on lankacidin-group (T-2636) antibiotics. 8. Metabolism of lankacidin C 14-propionate in rats and mice.
    Harada S; Tanayama S; Kishi T
    J Antibiot (Tokyo); 1973 Nov; 26(11):658-68. PubMed ID: 4792113
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on lankacidin-group (T-2636) antibiotics. V. Chemical structures of lankacidin-group antibiotics. 1.
    Harada S; Kishi T
    Chem Pharm Bull (Tokyo); 1974 Jan; 22(1):99-108. PubMed ID: 4833376
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on mycotrienin antibiotics, a novel class of ansamycins. IV. Microbial conversion of mycotrienin-II to mycotrienol-II, 34-hydroxymycotrienin-II and 22-O-beta-D-glucopyranosylmycotrienin-II by Bacillus megaterium.
    Sugita M; Hiramoto S; Ando C; Sasaki T; Furihata K; Seto H; Otake N
    J Antibiot (Tokyo); 1985 Jun; 38(6):799-802. PubMed ID: 3926737
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on lankacidin-group (T-2636) antibiotics. VI. Chemical structures of lankacidin-group antibiotics. II.
    Harada S
    Chem Pharm Bull (Tokyo); 1975 Oct; 23(10):2201-10. PubMed ID: 1212749
    [No Abstract]   [Full Text] [Related]  

  • 7. Side chain modifications in lankacidin group antibiotics.
    McFarland JW; Pirie DK; Retsema JA; English AR
    Antimicrob Agents Chemother; 1984 Feb; 25(2):226-33. PubMed ID: 6370129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on lankacidin-group (T-2636) antibiotics. VII. Structure-activity relationships of lankacidin-group antibiotics.
    Harada S; Yamazaki T; Hatano K; Tsuchiya K; Kishi T
    J Antibiot (Tokyo); 1973 Nov; 26(11):647-57. PubMed ID: 4792112
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumor and immunosuppressive activities of lankacidin-group antibiotics: structure-activity relationships.
    Oostu K; Matsumoto T; Harada S; Kishi T
    Cancer Chemother Rep; 1975; 59(5):919-28. PubMed ID: 1148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-beta-hyroxybutyrate metabolism in washed suspensions of Bacillus cereus and Bacillus megaterium.
    MACRAE RM; WILKINSON JF
    J Gen Microbiol; 1958 Aug; 19(1):210-22. PubMed ID: 13575769
    [No Abstract]   [Full Text] [Related]  

  • 11. Inclusion compounds of lankacidin-group antibiotics with cyclodextrins.
    Harada S; Okada J; Takeda M; Yamazaki T
    J Antibiot (Tokyo); 1985 Jul; 38(7):877-85. PubMed ID: 4030501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetamide hydrolyzing activity of Bacillus megaterium F-8 with bioremediation potential: optimization of production and reaction conditions.
    Sogani M; Bakre PP; Mathur N; Sharma P; Bhatnagar P
    Environ Sci Pollut Res Int; 2014; 21(14):8822-30. PubMed ID: 24723348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial conversion of antibiotics. I. Deacylation of maridomycin by bacteria.
    Nakahama K; Izawa M; Muroi M; Kishi T; Uchida M
    J Antibiot (Tokyo); 1974 Jun; 27(6):425-32. PubMed ID: 4212166
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of beta-lactam antibiotics with penicillin-binding proteins from Bacillus megaterium.
    Rodríguez-Tébar A; Rojo F; Vázquez D
    Eur J Biochem; 1982 Aug; 126(1):161-6. PubMed ID: 6813116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinspired computational design of lankacidin derivatives for improvement in antitumor activity.
    Ayoub AT; Nishiura N; Teshima A; Elrefaiy MA; Muslimin R; Do KM; Kodama T; Lewis CW; Chan G; Morita H; Arakawa K
    Future Med Chem; 2022 Oct; 14(19):1349-1360. PubMed ID: 36073363
    [No Abstract]   [Full Text] [Related]  

  • 16. Protein origin of the volatile fatty acids isobutyrate and isovalerate in human stool.
    Zarling EJ; Ruchim MA
    J Lab Clin Med; 1987 May; 109(5):566-70. PubMed ID: 3572204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exo- and endotrophic cells in a population of Bacillus megaterium].
    Ivanov VN; Nud'ga AIu
    Mikrobiol Zh (1978); 1990; 52(6):17-21. PubMed ID: 2129049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of Streptomyces cinnamonensis to butyrate and isobutyrate: production and properties of a new anti-isobutyrate (AIB) factor.
    Pospísil S
    J Gen Microbiol; 1991 Sep; 137(9):2141-6. PubMed ID: 1748869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cleavage of lactulose by Bacillus megaterium].
    Leuchtenberger A; Ruttloff H
    Z Allg Mikrobiol; 1978; 18(10):713-9. PubMed ID: 111429
    [No Abstract]   [Full Text] [Related]  

  • 20. SOME PROPERTIES OF A NEW BACTERIOCIN FORMED BY BACILLUS MEGATERIUM.
    HOLLAND IB; ROBERTS CF
    J Gen Microbiol; 1964 May; 35():271-85. PubMed ID: 14179674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.